Shiraz E-Medical Journal

Published by: Kowsar

Sesame a Treatment of Menstrual Bleeding Cessation in Iranian Traditional Medicine: Results From a Pilot Study

Maryam Yavari 1 , Safoura Rouholamin 2 , Mojgan Tansaz 1 , * , Soodabeh Bioos 3 and Somayeh Esmaeili 4
Authors Information
1 Departmant of Traditional Medicine, School of Traditional Medicine, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
2 Department of Obstetrics and Gynecology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, IR Iran
3 Faculty of Traditional Medicine, Tehran University of Medical Sciences, Tehran, IR Iran
4 Traditional Medicine and Materia Medica Research Center, Shahid Beheshti University of Medical Sciences, Tehran, IR Iran
Article information
  • Shiraz E-Medical Journal: July 01, 2014, 15 (3); e21893
  • Published Online: July 20, 2014
  • Article Type: Research Article
  • Received: November 10, 2013
  • Revised: December 20, 2013
  • Accepted: March 30, 2014
  • DOI: 10.17795/semj21893

To Cite: Yavari M, Rouholamin S, Tansaz M, Bioos S, Esmaeili S. Sesame a Treatment of Menstrual Bleeding Cessation in Iranian Traditional Medicine: Results From a Pilot Study, Shiraz E-Med J. 2014 ; 15(3):e21893. doi: 10.17795/semj21893.

Abstract
Copyright © 2014, Shiraz University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
References
  • 1. Tansaz M, Mokaberinejad R, Bioos S, Sohrabvand F, Emtiazy M. Avicenna aspect of premature ovarian failure. Iran J Reprod Med. 2013; 11(2): 167-8[PubMed]
  • 2. Panay N, Pritsch M, Alt J. Cyclical dydrogesterone in secondary amenorrhea: results of a double-blind, placebo-controlled, randomized study. Gynecol Endocrinol. 2007; 23(11): 611-8[DOI][PubMed]
  • 3. Cardigno P. Homeopathy for the treatment of menstrual irregularities: a case series. Homeopathy. 2009; 98(2): 97-106[DOI][PubMed]
  • 4. Taponen S, Martikainen H, Jarvelin MR, Laitinen J, Pouta A, Hartikainen AL, et al. Hormonal profile of women with self-reported symptoms of oligomenorrhea and/or hirsutism: Northern Finland birth cohort 1966 study. J Clin Endocrinol Metab. 2003; 88(1): 141-7[DOI][PubMed]
  • 5. van Hooff MH, Voorhorst FJ, Kaptein MB, Hirasing RA, Koppenaal C, Schoemaker J. Polycystic ovaries in adolescents and the relationship with menstrual cycle patterns, luteinizing hormone, androgens, and insulin. Fertil Steril. 2000; 74(1): 49-58[PubMed]
  • 6. Campbell S, Monga AK. Gynaecology By Ten Teachers. 2000;
  • 7. Devoto E, Aravena L, Gaete X. [Has oligomenorrhea a pathological meaning? The importance of this symptom in internal medicine]. Rev Med Chil. 1998; 126(8): 943-51[PubMed]
  • 8. Matsumoto J, Hata T. Re-evaluation of secondary amenorrheic patients one year after initial diagnosis: a prospective study. J Nippon Med Sch. 2004; 71(1): 63-8[PubMed]
  • 9. Ryan KJ, Bekowitz RS, Burbieri RL. Kistner's Gynecology and Women's Health. 2003;
  • 10. Fritz MA, Speroff L. Clinical Gynecologic Endocrinology and Infertility. 2005;
  • 11. Gallo MF, Nanda K, Grimes DA, Schulz KF. 20 mcg versus >20 mcg estrogen combined oral contraceptives for contraception. Cochrane Database Syst Rev. 2005; (2)[DOI][PubMed]
  • 12. Ross RK, Paganini-Hill A, Wan PC, Pike MC. Effect of hormone replacement therapy on breast cancer risk: estrogen versus estrogen plus progestin. J Natl Cancer Inst. 2000; 92(4): 328-32[PubMed]
  • 13. Ibn-e-sina (Avicenna Husain) . Al-Qanun fit-tib : [The Canon of Medicine]. 2005;
  • 14. Razi Mohammad ibn-e-Zakarya. . [ Alhavi al-kabir ] 2010;
  • 15. Heravi MG . [Qarabadin-e-salehi] 2004;
  • 16. Aquili Khorasani MH. Qarabadin Kabir 1386;
  • 17. Momen Tonekaboni M. Tohfe Momenin. 1386;
  • 18. Aquili MH. [Makhzan Al-Adviah]. 1388;
  • 19. Ashri A. Plant Breeding Reviews. 2010; 16
  • 20. Bedigian D, Harlan JR. Evidence for cultivation of sesame in the ancient world. Econ Botany. 1986; 40(2): 137-54[DOI]
  • 21. Bedigian D. COVER ARTICLE: History and Lore of Sesame in Southwest Asia. Econ Botany. 2004; 58(3): 330-53[DOI]
  • 22. Bedigian D, Seigler DS, Harlan JR. Sesamin, sesamolin and the origin of sesame. Biochem Syst Ecol. 1985; 13(2): 133-9[DOI]
  • 23. Fukuda Y, Nagata M, Osawa T, Namiki M. Contribution of lignan analogues to antioxidative activity of refined unroasted sesame seed oil. J Am Oil Chem Soc. 1986; 63(8): 1027-31[DOI]
  • 24. Food and Agriculture Organization . FAO Statistical Database. 2005;
  • 25. Dachtler M, van de Put FHM, van Stijn F. On-line LC-NMR-MS characterization of sesame oil extracts and assessment of their antioxidant activity. Eur J Lipid Sci Technol. 2003; 105: 488-96[DOI]
  • 26. Papadakis EN, Lazarou D, Grougnet R, Magiatis P, Skaltsounis AL, Papadopoulou-Mourkidou E, et al. Effect of the form of the sesame-based diet on the absorption of lignans. Br J Nutr. 2008; 100(6): 1213-9[DOI][PubMed]
  • 27. Anagnostis A, Papadopoulos AI. Effects of a diet rich in sesame ( Sesamum indicum) pericarp on the expression of oestrogen receptor alpha and oestrogen receptor beta in rat prostate and uterus. Br J Nutr. 2009; 102(5): 703-8[DOI][PubMed]
  • 28. Amini Mahabadi J, Hassani Bafrani H, Nikzad H, Taherian A, Eskandarinasab M, Shaheir M. Effect of a sesame seed regimen on the adult rat testicular structure. FEYZ. 2012; 16(4): 304-10
  • 29. Asghary S, Shirzad H, Heidarian E, Mirhosseini M, Ansari R, Shahinfard N. Effects of Sesamum indicum L. on fibrinogen and factor 7 in hypercholesterolemic rabbits. J Shahrekord Univ Med Sci. 2011; 13(1): 21-6
  • 30. Moran LJ, Hutchison SK, Meyer C, Zoungas S, Teede HJ. A comprehensive assessment of endothelial function in overweight women with and without polycystic ovary syndrome. Clin Sci (Lond). 2009; 116(10): 761-70[DOI][PubMed]
  • 31. Rajendran S, Willoughby SR, Chan WP, Liberts EA, Heresztyn T, Saha M, et al. Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects. Atherosclerosis. 2009; 204(2): 509-14[DOI][PubMed]
  • 32. Atiomo WU, Fox R, Condon JE, Shaw S, Friend J, Prentice AG, et al. Raised plasminogen activator inhibitor-1 (PAI-1) is not an independent risk factor in the polycystic ovary syndrome (PCOS). Clin Endocrinol (Oxf). 2000; 52(4): 487-92[PubMed]
  • 33. Manneras-Holm L, Baghaei F, Holm G, Janson PO, Ohlsson C, Lonn M, et al. Coagulation and fibrinolytic disturbances in women with polycystic ovary syndrome. J Clin Endocrinol Metab. 2011; 96(4): 1068-76[DOI][PubMed]
  • 34. Mokaberinejad R, Zafarghandi N, Bioos S, Dabaghian FH, Naseri M, Kamalinejad M, et al. Mentha longifolia syrup in secondary amenorrhea: a double-blind, placebo-controlled, randomized trials. Daru. 2012; 20(1): 97[DOI][PubMed]
  • 35. Lieman H, Santoro N. Premature Ovarian Failure: A Modern Approach to Diagnosis and Treatment. Endocrinol. 1997; 7(5): 314-21[DOI]
  • 36. Panay. N. , Kalu E. Management of premature ovarian failure. Best Pract Res Clin Obstet Gynae.
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiation Alert
via Google Reader

Readers' Comments